Laparoendoscopic Rendezvous for Concomitant Cholecystocholedocholithiasis: A Successful Modality Even in the Most Difficult Presentations Including Pregnancy

Abstract EN

Background.

Laparoendoscopic rendezvous (LERV) technique is emerging as an attractive treatment option for concomitant cholecystocholedocholithiasis.

In this paper, we report our experience in performing the LERV technique in patients with unusual presentations in terms of anatomical difficulty, pregnancy, multiple comorbid diseases, and postlaparotomy.

We aim to highlight the effectiveness of the LERV technique in some clinical situations where conventional methods would fail or carry high risks in adequately managing concomitant cholecystocholedocholithiasis.

Methods.

Four patients diagnosed to have concomitant cholecystocholedocholithiasis with associated difficult presentation or comorbid diseases were treated using the LERV technique.

One patient presented with difficult anatomy where ERCP failed at initial attempts.

Another patient was pregnant (first trimester).

A third patient had complex comorbid diseases (bronchial asthma, hypertension, congestive heart failure, and end-stage renal disease on regular hemodialysis).

A fourth patient had previous laparotomy and sigmoidectomy for diverticular disease and had severe hospital phobia.

Results.

All patients tolerated the LERV technique very well; no intraoperative occurrence was reported.

The mean operative time was 86.3±17.2 minutes; mean time of the endoscopic part was 29.4±3.57 minutes.

The mean blood loss was 44.3±18.2 mL (range 20–85).

Residual stone, postoperative complications, postoperative morbidity, and postoperative mortality were 0 (0%).

Postoperative short hospital stay was reported in all patients, average 3 days (range 2–4).

Conclusion.

LERV procedure is a safe and effective treatment option for the management of concomitant cholecystocholedocholithiasis, even in difficult situations where other methods would fail or carry high risks, or in patients presenting with severe comorbid diseases or pregnancy.

This procedure may emerge as an attractive alternative option for high-risk patients.

A patient’s wishes may also influence the selection of this procedure.

More scientific studies recruiting more patients should be done in order to standardize the LERV procedure.